A detailed history of Tower Research Capital LLC (Trc) transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 9,490 shares of VKTX stock, worth $401,616. This represents 0.02% of its overall portfolio holdings.

Number of Shares
9,490
Previous 20,512 53.73%
Holding current value
$401,616
Previous $1.09 Million 44.8%
% of portfolio
0.02%
Previous 0.02%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$49.84 - $70.47 $549,336 - $776,720
-11,022 Reduced 53.73%
9,490 $600,000
Q2 2024

Aug 13, 2024

BUY
$47.39 - $80.2 $907,802 - $1.54 Million
19,156 Added 1412.68%
20,512 $1.09 Million
Q1 2024

May 15, 2024

SELL
$17.4 - $94.5 $305,109 - $1.66 Million
-17,535 Reduced 92.82%
1,356 $111,000
Q4 2023

Feb 13, 2024

BUY
$9.24 - $19.64 $99,976 - $212,504
10,820 Added 134.06%
18,891 $351,000
Q3 2023

Nov 14, 2023

BUY
$10.92 - $16.0 $57,308 - $83,968
5,248 Added 185.9%
8,071 $89,000
Q2 2023

Aug 14, 2023

SELL
$14.84 - $24.79 $150,626 - $251,618
-10,150 Reduced 78.24%
2,823 $45,000
Q1 2023

May 09, 2023

BUY
$8.08 - $17.33 $75,879 - $162,746
9,391 Added 262.17%
12,973 $216,000
Q4 2022

Feb 10, 2023

BUY
$2.72 - $9.4 $7,980 - $27,579
2,934 Added 452.78%
3,582 $34,000
Q3 2022

Nov 10, 2022

BUY
$2.55 - $3.89 $1,642 - $2,505
644 Added 16100.0%
648 $2,000
Q2 2022

Aug 15, 2022

SELL
$2.11 - $3.15 $58,550 - $87,409
-27,749 Reduced 99.99%
4 $0
Q1 2022

May 12, 2022

SELL
$3.0 - $4.88 $96,003 - $156,164
-32,001 Reduced 53.55%
27,753 $83,000
Q4 2021

Feb 14, 2022

BUY
$4.6 - $6.72 $206,659 - $301,902
44,926 Added 302.98%
59,754 $275,000
Q3 2021

Nov 15, 2021

BUY
$5.58 - $7.04 $56,637 - $71,456
10,150 Added 216.97%
14,828 $94,000
Q2 2021

Aug 16, 2021

SELL
$5.19 - $6.73 $11,148 - $14,456
-2,148 Reduced 31.47%
4,678 $28,000
Q1 2021

May 17, 2021

SELL
$5.74 - $9.67 $23,568 - $39,705
-4,106 Reduced 37.56%
6,826 $43,000
Q4 2020

Feb 16, 2021

BUY
$5.3 - $6.71 $3,625 - $4,589
684 Added 6.67%
10,932 $61,000
Q3 2020

Nov 16, 2020

SELL
$5.73 - $8.11 $58,560 - $82,884
-10,220 Reduced 49.93%
10,248 $60,000
Q2 2020

Aug 13, 2020

BUY
$4.35 - $8.08 $88,600 - $164,573
20,368 Added 20368.0%
20,468 $148,000
Q1 2020

May 15, 2020

SELL
$3.45 - $7.95 $10,732 - $24,732
-3,111 Reduced 96.89%
100 $0
Q4 2019

Feb 07, 2020

SELL
$6.38 - $8.73 $30,560 - $41,816
-4,790 Reduced 59.87%
3,211 $26,000
Q3 2019

Nov 05, 2019

BUY
$6.55 - $8.6 $50,847 - $66,761
7,763 Added 3261.76%
8,001 $55,000
Q2 2019

Aug 13, 2019

BUY
$7.67 - $10.63 $1,825 - $2,529
238 New
238 $2,000
Q1 2019

May 14, 2019

SELL
$7.58 - $9.94 $60 - $79
-8 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$7.16 - $16.21 $57 - $129
8 New
8 $0

Others Institutions Holding VKTX

About Viking Therapeutics, Inc.


  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $3.25B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.